Krishna Vaddi, CEO at Prelude Therapeutics Inc (PRLD), bought 20,416 shares at $0.73 ($15K) on 2025-03-20, disclosed to the SEC on 2025-03-24.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.73 | 5,416 | $4K | 26.5% |
| 2 | $0.73 | 15,000 | $11K | 73.5% |
| Total | $0.73 avg | 20,416 | $15K | 100% |
| Filing → |
| PRLD | BUY | 2025-03-14 | $70K | — | Filing → |
| PRLD | BUY | 2025-01-03 | $6K | — | Filing → |
| PRLD | BUY | 2025-01-02 | $12K | — | Filing → |